Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Factors associated with non-adherence to antiretroviral therapy in the SUN study.

Kyser M, Buchacz K, Bush TJ, Conley LJ, Hammer J, Henry K, Kojic EM, Milam J, Overton ET, Wood KC, Brooks JT.

AIDS Care. 2011 May;23(5):601-11. doi: 10.1080/09540121.2010.525603.

PMID:
21293992
2.

Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians.

Grierson J, Koelmeyer RL, Smith A, Pitts M.

HIV Med. 2011 Oct;12(9):562-9. doi: 10.1111/j.1468-1293.2011.00928.x. Epub 2011 May 9.

3.

Gender and other psychosocial factors as predictors of adherence to highly active antiretroviral therapy (HAART) in adults with comorbid HIV/AIDS, psychiatric and substance-related disorder.

Applebaum AJ, Richardson MA, Brady SM, Brief DJ, Keane TM.

AIDS Behav. 2009 Feb;13(1):60-5. doi: 10.1007/s10461-008-9441-x. Epub 2008 Aug 9.

PMID:
18690532
4.

Factors associated with adherence to highly active antiretroviral therapy in homeless or unstably housed adults living with HIV.

Royal SW, Kidder DP, Patrabansh S, Wolitski RJ, Holtgrave DR, Aidala A, Pals S, Stall R.

AIDS Care. 2009 Apr;21(4):448-55. doi: 10.1080/09540120802270250.

PMID:
19401865
5.

HIV-infected patients' adherence to highly active antiretroviral therapy: a phenomenological study.

Mohammadpour A, Yekta ZP, Nikbakht Nasrabadi AR.

Nurs Health Sci. 2010 Dec;12(4):464-9. doi: 10.1111/j.1442-2018.2010.00560.x. Epub 2010 Nov 17.

PMID:
21210925
7.

Adherence to antiretroviral therapy: a survey of factors associated with medication usage.

Duggan JM, Locher A, Fink B, Okonta C, Chakraborty J.

AIDS Care. 2009 Sep;21(9):1141-7. doi: 10.1080/09540120902730039.

PMID:
20024773
8.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
9.
10.

Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.

McNabb J, Ross JW, Abriola K, Turley C, Nightingale CH, Nicolau DP.

Clin Infect Dis. 2001 Sep 1;33(5):700-5. Epub 2001 Jul 30.

11.

Risk-factors for non-adherence to antiretroviral therapy.

Silva MC, Ximenes RA, Miranda Filho DB, Arraes LW, Mendes M, Melo AC, Fernandes PR.

Rev Inst Med Trop Sao Paulo. 2009 May-Jun;51(3):135-9.

12.

The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.

Leombruni P, Fassino S, Lavagnino L, Orofino G, Morosini P, Picardi A.

Psychother Psychosom. 2009;78(4):254-7. doi: 10.1159/000219525. Epub 2009 May 21.

PMID:
19468260
13.

Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders.

Mellins CA, Havens JF, McDonnell C, Lichtenstein C, Uldall K, Chesney M, Santamaria EK, Bell J.

AIDS Care. 2009 Feb;21(2):168-77. doi: 10.1080/09540120802001705.

PMID:
19229685
15.

Harm reduction intensity-Its role in HAART adherence amongst drug users in Amsterdam.

Lambers FA, Stolte IG, van den Berg CH, Coutinho RA, Prins M.

Int J Drug Policy. 2011 May;22(3):210-8. doi: 10.1016/j.drugpo.2011.02.004. Epub 2011 Mar 9.

16.

Psychological distress and adherence to highly active anti-retroviral therapy (HAART) in Uganda: a pilot study.

Nakimuli-Mpungu E, Mutamba B, Othengo M, Musisi S.

Afr Health Sci. 2009 Aug 1;9 Suppl 1:S2-7.

17.

Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients.

Kumar V, Encinosa W.

Psychiatr Q. 2009 Sep;80(3):131-41. doi: 10.1007/s11126-009-9100-z. Epub 2009 Apr 22.

PMID:
19387832
18.

Adherence is not a barrier to successful antiretroviral therapy in South Africa.

Orrell C, Bangsberg DR, Badri M, Wood R.

AIDS. 2003 Jun 13;17(9):1369-75.

PMID:
12799558
19.

Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.

Webb MS, Vanable PA, Carey MP, Blair DC.

AIDS Educ Prev. 2009 Jun;21(3 Suppl):94-105. doi: 10.1521/aeap.2009.21.3_supp.94.

PMID:
19537957
20.

Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use.

Palepu A, Tyndall M, Yip B, O'Shaughnessy MV, Hogg RS, Montaner JS.

J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):522-6.

PMID:
12679704
Items per page

Supplemental Content

Write to the Help Desk